Changes in peripheral blood level of regulatory T cells in patients with malignant melanoma during treatment with dendritic cell vaccination and low-dose IL-2

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Standard

Changes in peripheral blood level of regulatory T cells in patients with malignant melanoma during treatment with dendritic cell vaccination and low-dose IL-2. / Bjoern, J; Brimnes, M K; Andersen, M H; Straten, Per thor; Svane, I M.

I: Scandinavian Journal of Immunology, Bind 73, Nr. 3, 2011, s. 222-33.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Harvard

Bjoern, J, Brimnes, MK, Andersen, MH, Straten, PT & Svane, IM 2011, 'Changes in peripheral blood level of regulatory T cells in patients with malignant melanoma during treatment with dendritic cell vaccination and low-dose IL-2', Scandinavian Journal of Immunology, bind 73, nr. 3, s. 222-33. https://doi.org/10.1111/j.1365-3083.2010.02494.x

APA

Bjoern, J., Brimnes, M. K., Andersen, M. H., Straten, P. T., & Svane, I. M. (2011). Changes in peripheral blood level of regulatory T cells in patients with malignant melanoma during treatment with dendritic cell vaccination and low-dose IL-2. Scandinavian Journal of Immunology, 73(3), 222-33. https://doi.org/10.1111/j.1365-3083.2010.02494.x

Vancouver

Bjoern J, Brimnes MK, Andersen MH, Straten PT, Svane IM. Changes in peripheral blood level of regulatory T cells in patients with malignant melanoma during treatment with dendritic cell vaccination and low-dose IL-2. Scandinavian Journal of Immunology. 2011;73(3):222-33. https://doi.org/10.1111/j.1365-3083.2010.02494.x

Author

Bjoern, J ; Brimnes, M K ; Andersen, M H ; Straten, Per thor ; Svane, I M. / Changes in peripheral blood level of regulatory T cells in patients with malignant melanoma during treatment with dendritic cell vaccination and low-dose IL-2. I: Scandinavian Journal of Immunology. 2011 ; Bind 73, Nr. 3. s. 222-33.

Bibtex

@article{ac18b4dd1a034e6483fde20bc9a3b487,

title = "Changes in peripheral blood level of regulatory T cells in patients with malignant melanoma during treatment with dendritic cell vaccination and low-dose IL-2",

abstract = "In this study, changes in peripheral blood regulatory T cell (Treg) levels were evaluated in 46 progressive patients with melanoma treated with a dendritic cell-based vaccine and concomitant low-dose IFN-a and IL-2. The regulatory subset of CD4 T cells, characterized by CD25(high) , was prospectively analysed in fresh blood, and treatment-associated quantitative and qualitative changes were analysed. By the 4th vaccine, patients showed a marked increase in CD4+ CD25(high) T cell subset from 6% to 22% (P",

author = "J Bjoern and Brimnes, {M K} and Andersen, {M H} and Straten, {Per thor} and Svane, {I M}",

note = "{\textcopyright} 2011 The Authors. Scandinavian Journal of Immunology {\textcopyright} 2011 Blackwell Publishing Ltd.",

year = "2011",

doi = "http://dx.doi.org/10.1111/j.1365-3083.2010.02494.x",

language = "English",

volume = "73",

pages = "222--33",

journal = "Scandinavian Journal of Immunology, Supplement",

issn = "0301-6323",

publisher = "Wiley-Blackwell",

number = "3",

}

RIS

TY - JOUR

T1 - Changes in peripheral blood level of regulatory T cells in patients with malignant melanoma during treatment with dendritic cell vaccination and low-dose IL-2

AU - Bjoern, J

AU - Brimnes, M K

AU - Andersen, M H

AU - Straten, Per thor

AU - Svane, I M

PY - 2011

Y1 - 2011

N2 - In this study, changes in peripheral blood regulatory T cell (Treg) levels were evaluated in 46 progressive patients with melanoma treated with a dendritic cell-based vaccine and concomitant low-dose IFN-a and IL-2. The regulatory subset of CD4 T cells, characterized by CD25(high) , was prospectively analysed in fresh blood, and treatment-associated quantitative and qualitative changes were analysed. By the 4th vaccine, patients showed a marked increase in CD4+ CD25(high) T cell subset from 6% to 22% (P

AB - In this study, changes in peripheral blood regulatory T cell (Treg) levels were evaluated in 46 progressive patients with melanoma treated with a dendritic cell-based vaccine and concomitant low-dose IFN-a and IL-2. The regulatory subset of CD4 T cells, characterized by CD25(high) , was prospectively analysed in fresh blood, and treatment-associated quantitative and qualitative changes were analysed. By the 4th vaccine, patients showed a marked increase in CD4+ CD25(high) T cell subset from 6% to 22% (P

U2 - http://dx.doi.org/10.1111/j.1365-3083.2010.02494.x

DO - http://dx.doi.org/10.1111/j.1365-3083.2010.02494.x

M3 - Journal article

VL - 73

SP - 222

EP - 233

JO - Scandinavian Journal of Immunology, Supplement

JF - Scandinavian Journal of Immunology, Supplement

SN - 0301-6323

IS - 3

ER -

ID: 40197021